Viking Therapeutics
Tracked across 2 events · 12 articles · First seen May 08, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Viking Therapeutics is listed among emerging players in the obesity therapeutics market.
May 08, 2026 · 6 articles
Business
Eli Lilly and Company shares fell roughly 7-8% over the month preceding mid-September 2026, sliding from about $1,255 to around $1,115-1,165, even as the broader S&P 500 advanced. The decline followed realized U.S. price declines…
Impact: Clinical-stage biotech peer cited for its roughly 207% implied upside, reflecting binary trial risk rather than franchise strength. Serves as a contrast to Lilly's cash-generative large-cap setup.
Sep 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Viking Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard